Amarantus Bioscience Holdings, Inc.
SEC CIK 1424812 · AMBS · last insider filing 2017-11-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Wei Rongguo | Director · Chief Financial Officer | filed 2017 - 2017 |
| Flanigan Conn | Director | filed 2017 - 2017 |
| Trapp Robert H | Director | filed 2017 - 2017 |
| Spence Steven | Director | filed 2017 - 2017 |
| Commissiong Gerald | Director · CEO | filed 2013 - 2016 |
| Harris Robert Lewis | Director | filed 2013 - 2015 |
| Farrell Robert Edward | Director · Chief Financial Officer | filed 2014 - 2015 |
| Rubinfeld Joseph | Director | filed 2014 - 2015 |
| Commissiong John Wesley | Director · Chief Scientific Officer | filed 2015 - 2015 |
| Huffman Donald D | Director | filed 2014 - 2015 |
| Gladstone Ross Iain | Director | filed 2014 - 2015 |
| Lowe David A | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Faerber Marc E | See Remarks | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.